The Confederation of the Traders of All Indian Traders (CAIT) on Friday approached the Securities and the Council of India (SEBI), urged the market regulator not to allow the e-player pharmaceutical player to continue plans for the initial public offering (IPO)).

N Written representation, CAIT asked SBI Chairperson Ajay Tyagi “to reject the draft Red Herring Prospectus (DRHP) from the Fire Holdings Ltd, which has Farmureasy”.

Cait cited the 2018 Delhi High Court order that prohibits the sale of drugs online and said, “We Cait is the peak body of the merchant association from all over India.

CAIT is further recorded in the representation that “the sale of drugs is still continuing until this date against the commandment by the High Court. The insult of the court process is still delayed against all parties in the case. The Ministry of Health & Welfare of the Family, the Government of India, in a delayed statement before The Delhi High Court, has admitted that: the sale of drugs online is currently being considered by the government; drug law and cosmetics, 1940, and the 1945 regulation has no provision. “

Cait National Secretary General Praveen Khandelwal said it would be inappropriate for SEBI to allow Pharmaceutical GO PUBLIC. “The Fire Holdings have proposed to acquire the Pathology Thyrocare lab a few months ago. However, there is no order passed by the Indian Competition Commission (CCI) in this matter. Despite the lack of CCI orders, fire Holdings said a subsidiary as a subsidiary as a subsidiary as a subsidiary as a subsidiary as a subsidiary as a subsidiary Subsidiaries in DRHP were submitted to Sebi. SCDA has also sent a letter to CCI who is looking for clarification but even after several reminders, do not receive a response, “Khandelwal.